APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Second Opinion

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

Selected research

Market Analysis & Forecast

Global Medical Second Opinion Market Analysis and Forecast 2026-2032

20 December 2025209 pages

Choose your research edition.

Industry ResearchMedical Second Opinion Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Second Opinion Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Medical Second Opinion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Second Opinion Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Second Opinion Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

The major players in global Medical Second Opinion market include HCA Hospitals, AXA PPP Healthcare, Royal London Group, etc. The top 3 players occupy about 20% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Hospitals is the main type, with a share about 45%. Cancer is the main application, which holds a share about 25%.

Report Includes

Read the full market overview

This report presents an overview of global market for Medical Second Opinion, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Second Opinion, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Second Opinion, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Second Opinion revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Second Opinion market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Second Opinion revenue, projected growth trends, production technology, application and end-user industry.

Medical Second Opinion Segment by Company

HCA Hospitals

AXA PPP Healthcare

Royal London Group

Helsana Group

Cleveland Clinic

Amradnet

Best Doctors Inc

Inova Care

Toranomon Hospital

Keio University Hospital

Johns Hopkins Medicine

Penn Medicine

Oncology International Pvt. Ltd.

GrandOpinion

London Pain Clinic

Mondial Assistance

Medisense

Medo Asia Sdn. Bhd.

Medical Second Opinion Segment by Type

Hospitals

Medical Second Opinion Providing Companies

Health Insurance Companies

Medical Second Opinion Segment by Application

Cancer

Diabetes

Cardiac Disorders

Neurological Disorders

Ocular Disorders

Others

Medical Second Opinion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Second Opinion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Second Opinion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Second Opinion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medical Second Opinion in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medical Second Opinion company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Second Opinion revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Second Opinion Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hospitals Major Player Table 3. Medical Second Opinion Providing Companies Major Player Table 4. Health Insurance Companies Major Player Table 5. Global Medical Second Opinion Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cancer Major Player Table 7. Diabetes Major Player Table 8. Cardiac Disorders Major Player Table 9. Neurological Disorders Major Player Table 10. Ocular Disorders Major Player Table 11. Others Major Player Table 12. Medical Second Opinion Industry Trends Table 13. Medical Second Opinion Industry Drivers Table 14. Medical Second Opinion Industry Opportunities and Challenges Table 15. Medical Second Opinion Industry Restraints Table 16. Global Medical Second Opinion Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Medical Second Opinion Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Medical Second Opinion Market Share by Region (2021-2026) Table 19. Global Medical Second Opinion Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Medical Second Opinion Market Share by Region (2027-2032) Table 21. Global Medical Second Opinion Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Medical Second Opinion Revenue Market Share by Players (2021-2026) Table 23. Global Medical Second Opinion Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Medical Second Opinion Key Players Headquarters & Area Served Table 25. Global Medical Second Opinion Players, Product Type & Application Table 26. Global Medical Second Opinion Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Medical Second Opinion by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Medical Second Opinion Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Medical Second Opinion Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Medical Second Opinion Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Medical Second Opinion Revenue Market Share by Type (2021-2026) Table 33. Global Medical Second Opinion Revenue Market Share by Type (2027-2032) Table 34. Global Medical Second Opinion Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Medical Second Opinion Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Medical Second Opinion Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Medical Second Opinion Revenue Market Share by Application (2021-2026) Table 38. Global Medical Second Opinion Revenue Market Share by Application (2027-2032) Table 39. HCA Hospitals Company Information Table 40. HCA Hospitals Business Overview Table 41. HCA Hospitals Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. HCA Hospitals Medical Second Opinion Product Portfolio Table 43. HCA Hospitals Recent Development Table 44. AXA PPP Healthcare Company Information Table 45. AXA PPP Healthcare Business Overview Table 46. AXA PPP Healthcare Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. AXA PPP Healthcare Medical Second Opinion Product Portfolio Table 48. AXA PPP Healthcare Recent Development Table 49. Royal London Group Company Information Table 50. Royal London Group Business Overview Table 51. Royal London Group Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Royal London Group Medical Second Opinion Product Portfolio Table 53. Royal London Group Recent Development Table 54. Helsana Group Company Information Table 55. Helsana Group Business Overview Table 56. Helsana Group Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Helsana Group Medical Second Opinion Product Portfolio Table 58. Helsana Group Recent Development Table 59. Cleveland Clinic Company Information Table 60. Cleveland Clinic Business Overview Table 61. Cleveland Clinic Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Cleveland Clinic Medical Second Opinion Product Portfolio Table 63. Cleveland Clinic Recent Development Table 64. Amradnet Company Information Table 65. Amradnet Business Overview Table 66. Amradnet Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Amradnet Medical Second Opinion Product Portfolio Table 68. Amradnet Recent Development Table 69. Best Doctors Inc Company Information Table 70. Best Doctors Inc Business Overview Table 71. Best Doctors Inc Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Best Doctors Inc Medical Second Opinion Product Portfolio Table 73. Best Doctors Inc Recent Development Table 74. Inova Care Company Information Table 75. Inova Care Business Overview Table 76. Inova Care Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Inova Care Medical Second Opinion Product Portfolio Table 78. Inova Care Recent Development Table 79. Toranomon Hospital Company Information Table 80. Toranomon Hospital Business Overview Table 81. Toranomon Hospital Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Toranomon Hospital Medical Second Opinion Product Portfolio Table 83. Toranomon Hospital Recent Development Table 84. Keio University Hospital Company Information Table 85. Keio University Hospital Business Overview Table 86. Keio University Hospital Medical Second Opinion Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Keio University Hospital Medical Second Opinion Product Portfolio Table 88. Keio University Hospital Recent Development Table 89. Johns Hopkins Medicine Company Information Table 90. Johns Hopkins Medicine Business Overview Table 91. Johns Hopkins Medicine Medical Second Opinion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Johns Hopkins Medicine Medical Second Opinion Product Portfolio Table 93. Johns Hopkins Medicine Recent Development Table 94. Penn Medicine Company Information Table 95. Penn Medicine Business Overview Table 96. Penn Medicine Medical Second Opinion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Penn Medicine Medical Second Opinion Product Portfolio Table 98. Penn Medicine Recent Development Table 99. Oncology International Pvt. Ltd. Company Information Table 100. Oncology International Pvt. Ltd. Business Overview Table 101. Oncology International Pvt. Ltd. Medical Second Opinion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Oncology International Pvt. Ltd. Medical Second Opinion Product Portfolio Table 103. Oncology International Pvt. Ltd. Recent Development Table 104. GrandOpinion Company Information Table 105. GrandOpinion Business Overview Table 106. GrandOpinion Medical Second Opinion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. GrandOpinion Medical Second Opinion Product Portfolio Table 108. GrandOpinion Recent Development Table 109. London Pain Clinic Company Information Table 110. London Pain Clinic Business Overview Table 111. London Pain Clinic Medical Second Opinion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. London Pain Clinic Medical Second Opinion Product Portfolio Table 113. London Pain Clinic Recent Development Table 114. Mondial Assistance Company Information Table 115. Mondial Assistance Business Overview Table 116. Mondial Assistance Medical Second Opinion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Mondial Assistance Medical Second Opinion Product Portfolio Table 118. Mondial Assistance Recent Development Table 119. Medisense Company Information Table 120. Medisense Business Overview Table 121. Medisense Medical Second Opinion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Medisense Medical Second Opinion Product Portfolio Table 123. Medisense Recent Development Table 124. Medo Asia Sdn. Bhd. Company Information Table 125. Medo Asia Sdn. Bhd. Business Overview Table 126. Medo Asia Sdn. Bhd. Medical Second Opinion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Medo Asia Sdn. Bhd. Medical Second Opinion Product Portfolio Table 128. Medo Asia Sdn. Bhd. Recent Development Table 129. North America Medical Second Opinion Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Medical Second Opinion Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Medical Second Opinion Revenue by Application (2021-2026) & (US$ Million) Table 132. North America Medical Second Opinion Revenue by Application (2027-2032) & (US$ Million) Table 133. North America Medical Second Opinion Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Medical Second Opinion Revenue by Country (2021-2026) & (US$ Million) Table 135. North America Medical Second Opinion Revenue by Country (US$ Million) & (2027-2032) Table 136. Europe Medical Second Opinion Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Medical Second Opinion Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Medical Second Opinion Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Medical Second Opinion Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Medical Second Opinion Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Medical Second Opinion Revenue by Country (2021-2026) & (US$ Million) Table 142. Europe Medical Second Opinion Revenue by Country (US$ Million) & (2027-2032) Table 143. China Medical Second Opinion Revenue by Type (2021-2026) & (US$ Million) Table 144. China Medical Second Opinion Revenue by Type (2027-2032) & (US$ Million) Table 145. China Medical Second Opinion Revenue by Application (2021-2026) & (US$ Million) Table 146. China Medical Second Opinion Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Medical Second Opinion Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Medical Second Opinion Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Medical Second Opinion Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Medical Second Opinion Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Medical Second Opinion Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Medical Second Opinion Revenue by Region (US$ Million) & (2021-2026) Table 153. Asia Medical Second Opinion Revenue by Region (US$ Million) & (2027-2032) Table 154. SAMEA Medical Second Opinion Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Medical Second Opinion Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Medical Second Opinion Revenue by Application (2021-2026) & (US$ Million) Table 157. SAMEA Medical Second Opinion Revenue by Application (2027-2032) & (US$ Million) Table 158. SAMEA Medical Second Opinion Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. SAMEA Medical Second Opinion Revenue by Country (2021-2026) & (US$ Million) Table 160. SAMEA Medical Second Opinion Revenue by Country (US$ Million) & (2027-2032) Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Medical Second Opinion Image Figure 2. Global Medical Second Opinion Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Second Opinion Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hospitals Image Figure 5. Medical Second Opinion Providing Companies Image Figure 6. Health Insurance Companies Image Figure 7. Global Medical Second Opinion Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Medical Second Opinion Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cancer Image Figure 10. Diabetes Image Figure 11. Cardiac Disorders Image Figure 12. Neurological Disorders Image Figure 13. Ocular Disorders Image Figure 14. Others Image Figure 15. Global Medical Second Opinion Market Size (US$ Million) & (2021-2032) Figure 16. Global Medical Second Opinion Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Medical Second Opinion Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Medical Second Opinion Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Medical Second Opinion Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Medical Second Opinion Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Medical Second Opinion Revenue Market Share by Type (2021-2032) Figure 23. Global Medical Second Opinion Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Medical Second Opinion Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Medical Second Opinion Revenue Market Share by Application (2021-2032) Figure 26. North America Medical Second Opinion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Medical Second Opinion Revenue Share by Type (2021-2032) Figure 28. North America Medical Second Opinion Revenue Share by Application (2021-2032) Figure 29. North America Medical Second Opinion Revenue Share by Country (2021-2032) Figure 30. United States Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Medical Second Opinion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Medical Second Opinion Revenue Share by Type (2021-2032) Figure 35. Europe Medical Second Opinion Revenue Share by Application (2021-2032) Figure 36. Europe Medical Second Opinion Revenue Share by Country (2021-2032) Figure 37. Germany Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Medical Second Opinion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Medical Second Opinion Revenue Share by Type (2021-2032) Figure 47. China Medical Second Opinion Revenue Share by Application (2021-2032) Figure 48. Asia Medical Second Opinion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Medical Second Opinion Revenue Share by Type (2021-2032) Figure 50. Asia Medical Second Opinion Revenue Share by Application (2021-2032) Figure 51. Asia Medical Second Opinion Revenue Share by Region (2021-2032) Figure 52. Japan Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Medical Second Opinion Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Medical Second Opinion Revenue Share by Type (2021-2032) Figure 60. SAMEA Medical Second Opinion Revenue Share by Application (2021-2032) Figure 61. SAMEA Medical Second Opinion Revenue Share by Country (2021-2032) Figure 62. Brazil Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Medical Second Opinion Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Hospitals
  • Medical Second Opinion Providing Companies
  • Health Insurance Companies
Applications
  • Cancer
  • Diabetes
  • Cardiac Disorders
  • Neurological Disorders
  • Ocular Disorders
  • Others
Companies covered
  • HCA Hospitals
  • AXA PPP Healthcare
  • Royal London Group
  • Helsana Group
  • Cleveland Clinic
  • Amradnet
  • Best Doctors Inc
  • Inova Care
  • Toranomon Hospital
  • Keio University Hospital
  • Johns Hopkins Medicine
  • Penn Medicine
  • Oncology International Pvt. Ltd.
  • GrandOpinion
  • London Pain Clinic
  • Mondial Assistance
  • Medisense
  • Medo Asia Sdn. Bhd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Second Opinion Market by Type
  3. 1.2.1 Global Medical Second Opinion Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hospitals
  5. 1.2.3 Medical Second Opinion Providing Companies
  6. 1.2.4 Health Insurance Companies
  7. 1.3 Medical Second Opinion Market by Application
  8. 1.3.1 Global Medical Second Opinion Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer
  10. 1.3.3 Diabetes
  11. 1.3.4 Cardiac Disorders
  12. 1.3.5 Neurological Disorders
  13. 1.3.6 Ocular Disorders
  14. 1.3.7 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Medical Second Opinion Market Dynamics
  1. 2.1 Medical Second Opinion Industry Trends
  2. 2.2 Medical Second Opinion Industry Drivers
  3. 2.3 Medical Second Opinion Industry Opportunities and Challenges
  4. 2.4 Medical Second Opinion Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medical Second Opinion Market Perspective (2021-2032)
  2. 3.2 Global Medical Second Opinion Growth Trends by Region
  3. 3.2.1 Global Medical Second Opinion Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Second Opinion Market Size by Region (2021-2026)
  5. 3.2.3 Global Medical Second Opinion Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medical Second Opinion Revenue by Players
  2. 4.1.1 Global Medical Second Opinion Revenue by Players (2021-2026)
  3. 4.1.2 Global Medical Second Opinion Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medical Second Opinion Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Second Opinion Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medical Second Opinion Key Players Headquarters & Area Served
  7. 4.4 Global Medical Second Opinion Players, Product Type & Application
  8. 4.5 Global Medical Second Opinion Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medical Second Opinion Market CR5 and HHI
  11. 4.6.3 2025 Medical Second Opinion Tier 1, Tier 2, and Tier 3
5 Medical Second Opinion Market Size by Type
  1. 5.1 Global Medical Second Opinion Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Second Opinion Revenue by Type (2021-2032)
  3. 5.3 Global Medical Second Opinion Revenue Market Share by Type (2021-2032)
6 Medical Second Opinion Market Size by Application
  1. 6.1 Global Medical Second Opinion Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medical Second Opinion Revenue by Application (2021-2032)
  3. 6.3 Global Medical Second Opinion Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 HCA Hospitals
  2. 7.1.1 HCA Hospitals Company Information
  3. 7.1.2 HCA Hospitals Business Overview
  4. 7.1.3 HCA Hospitals Medical Second Opinion Revenue and Gross Margin (2021-2026)
  5. 7.1.4 HCA Hospitals Medical Second Opinion Product Portfolio
  6. 7.1.5 HCA Hospitals Recent Developments
  7. 7.2 AXA PPP Healthcare
  8. 7.2.1 AXA PPP Healthcare Company Information
  9. 7.2.2 AXA PPP Healthcare Business Overview
  10. 7.2.3 AXA PPP Healthcare Medical Second Opinion Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AXA PPP Healthcare Medical Second Opinion Product Portfolio
  12. 7.2.5 AXA PPP Healthcare Recent Developments
  13. 7.3 Royal London Group
  14. 7.3.1 Royal London Group Company Information
  15. 7.3.2 Royal London Group Business Overview
  16. 7.3.3 Royal London Group Medical Second Opinion Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Royal London Group Medical Second Opinion Product Portfolio
  18. 7.3.5 Royal London Group Recent Developments
  19. 7.4 Helsana Group
  20. 7.4.1 Helsana Group Company Information
  21. 7.4.2 Helsana Group Business Overview
  22. 7.4.3 Helsana Group Medical Second Opinion Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Helsana Group Medical Second Opinion Product Portfolio
  24. 7.4.5 Helsana Group Recent Developments
  25. 7.5 Cleveland Clinic
  26. 7.5.1 Cleveland Clinic Company Information
  27. 7.5.2 Cleveland Clinic Business Overview
  28. 7.5.3 Cleveland Clinic Medical Second Opinion Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cleveland Clinic Medical Second Opinion Product Portfolio
  30. 7.5.5 Cleveland Clinic Recent Developments
  31. 7.6 Amradnet
  32. 7.6.1 Amradnet Company Information
  33. 7.6.2 Amradnet Business Overview
  34. 7.6.3 Amradnet Medical Second Opinion Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Amradnet Medical Second Opinion Product Portfolio
  36. 7.6.5 Amradnet Recent Developments
  37. 7.7 Best Doctors Inc
  38. 7.7.1 Best Doctors Inc Company Information
  39. 7.7.2 Best Doctors Inc Business Overview
  40. 7.7.3 Best Doctors Inc Medical Second Opinion Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Best Doctors Inc Medical Second Opinion Product Portfolio
  42. 7.7.5 Best Doctors Inc Recent Developments
  43. 7.8 Inova Care
  44. 7.8.1 Inova Care Company Information
  45. 7.8.2 Inova Care Business Overview
  46. 7.8.3 Inova Care Medical Second Opinion Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Inova Care Medical Second Opinion Product Portfolio
  48. 7.8.5 Inova Care Recent Developments
  49. 7.9 Toranomon Hospital
  50. 7.9.1 Toranomon Hospital Company Information
  51. 7.9.2 Toranomon Hospital Business Overview
  52. 7.9.3 Toranomon Hospital Medical Second Opinion Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Toranomon Hospital Medical Second Opinion Product Portfolio
  54. 7.9.5 Toranomon Hospital Recent Developments
  55. 7.10 Keio University Hospital
  56. 7.10.1 Keio University Hospital Company Information
  57. 7.10.2 Keio University Hospital Business Overview
  58. 7.10.3 Keio University Hospital Medical Second Opinion Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Keio University Hospital Medical Second Opinion Product Portfolio
  60. 7.10.5 Keio University Hospital Recent Developments
  61. 7.11 Johns Hopkins Medicine
  62. 7.11.1 Johns Hopkins Medicine Company Information
  63. 7.11.2 Johns Hopkins Medicine Business Overview
  64. 7.11.3 Johns Hopkins Medicine Medical Second Opinion Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Johns Hopkins Medicine Medical Second Opinion Product Portfolio
  66. 7.11.5 Johns Hopkins Medicine Recent Developments
  67. 7.12 Penn Medicine
  68. 7.12.1 Penn Medicine Company Information
  69. 7.12.2 Penn Medicine Business Overview
  70. 7.12.3 Penn Medicine Medical Second Opinion Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Penn Medicine Medical Second Opinion Product Portfolio
  72. 7.12.5 Penn Medicine Recent Developments
  73. 7.13 Oncology International Pvt. Ltd.
  74. 7.13.1 Oncology International Pvt. Ltd. Company Information
  75. 7.13.2 Oncology International Pvt. Ltd. Business Overview
  76. 7.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Product Portfolio
  78. 7.13.5 Oncology International Pvt. Ltd. Recent Developments
  79. 7.14 GrandOpinion
  80. 7.14.1 GrandOpinion Company Information
  81. 7.14.2 GrandOpinion Business Overview
  82. 7.14.3 GrandOpinion Medical Second Opinion Revenue and Gross Margin (2021-2026)
  83. 7.14.4 GrandOpinion Medical Second Opinion Product Portfolio
  84. 7.14.5 GrandOpinion Recent Developments
  85. 7.15 London Pain Clinic
  86. 7.15.1 London Pain Clinic Company Information
  87. 7.15.2 London Pain Clinic Business Overview
  88. 7.15.3 London Pain Clinic Medical Second Opinion Revenue and Gross Margin (2021-2026)
  89. 7.15.4 London Pain Clinic Medical Second Opinion Product Portfolio
  90. 7.15.5 London Pain Clinic Recent Developments
  91. 7.16 Mondial Assistance
  92. 7.16.1 Mondial Assistance Company Information
  93. 7.16.2 Mondial Assistance Business Overview
  94. 7.16.3 Mondial Assistance Medical Second Opinion Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Mondial Assistance Medical Second Opinion Product Portfolio
  96. 7.16.5 Mondial Assistance Recent Developments
  97. 7.17 Medisense
  98. 7.17.1 Medisense Company Information
  99. 7.17.2 Medisense Business Overview
  100. 7.17.3 Medisense Medical Second Opinion Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Medisense Medical Second Opinion Product Portfolio
  102. 7.17.5 Medisense Recent Developments
  103. 7.18 Medo Asia Sdn. Bhd.
  104. 7.18.1 Medo Asia Sdn. Bhd. Company Information
  105. 7.18.2 Medo Asia Sdn. Bhd. Business Overview
  106. 7.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Product Portfolio
  108. 7.18.5 Medo Asia Sdn. Bhd. Recent Developments
8 North America
  1. 8.1 North America Medical Second Opinion Revenue (2021-2032)
  2. 8.2 North America Medical Second Opinion Revenue by Type (2021-2032)
  3. 8.2.1 North America Medical Second Opinion Revenue by Type (2021-2026)
  4. 8.2.2 North America Medical Second Opinion Revenue by Type (2027-2032)
  5. 8.3 North America Medical Second Opinion Revenue Share by Type (2021-2032)
  6. 8.4 North America Medical Second Opinion Revenue by Application (2021-2032)
  7. 8.4.1 North America Medical Second Opinion Revenue by Application (2021-2026)
  8. 8.4.2 North America Medical Second Opinion Revenue by Application (2027-2032)
  9. 8.5 North America Medical Second Opinion Revenue Share by Application (2021-2032)
  10. 8.6 North America Medical Second Opinion Revenue by Country
  11. 8.6.1 North America Medical Second Opinion Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medical Second Opinion Revenue by Country (2021-2026)
  13. 8.6.3 North America Medical Second Opinion Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medical Second Opinion Revenue (2021-2032)
  2. 9.2 Europe Medical Second Opinion Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medical Second Opinion Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medical Second Opinion Revenue by Type (2027-2032)
  5. 9.3 Europe Medical Second Opinion Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medical Second Opinion Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medical Second Opinion Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medical Second Opinion Revenue by Application (2027-2032)
  9. 9.5 Europe Medical Second Opinion Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medical Second Opinion Revenue by Country
  11. 9.6.1 Europe Medical Second Opinion Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medical Second Opinion Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medical Second Opinion Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medical Second Opinion Revenue (2021-2032)
  2. 10.2 China Medical Second Opinion Revenue by Type (2021-2032)
  3. 10.2.1 China Medical Second Opinion Revenue by Type (2021-2026)
  4. 10.2.2 China Medical Second Opinion Revenue by Type (2027-2032)
  5. 10.3 China Medical Second Opinion Revenue Share by Type (2021-2032)
  6. 10.4 China Medical Second Opinion Revenue by Application (2021-2032)
  7. 10.4.1 China Medical Second Opinion Revenue by Application (2021-2026)
  8. 10.4.2 China Medical Second Opinion Revenue by Application (2027-2032)
  9. 10.5 China Medical Second Opinion Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Second Opinion Revenue (2021-2032)
  2. 11.2 Asia Medical Second Opinion Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medical Second Opinion Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medical Second Opinion Revenue by Type (2027-2032)
  5. 11.3 Asia Medical Second Opinion Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medical Second Opinion Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medical Second Opinion Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medical Second Opinion Revenue by Application (2027-2032)
  9. 11.5 Asia Medical Second Opinion Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medical Second Opinion Revenue by Country
  11. 11.6.1 Asia Medical Second Opinion Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medical Second Opinion Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medical Second Opinion Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Second Opinion Revenue (2021-2032)
  2. 12.2 SAMEA Medical Second Opinion Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medical Second Opinion Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medical Second Opinion Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medical Second Opinion Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medical Second Opinion Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medical Second Opinion Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medical Second Opinion Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medical Second Opinion Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medical Second Opinion Revenue by Country
  11. 12.6.1 SAMEA Medical Second Opinion Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medical Second Opinion Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medical Second Opinion Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst